Table 1.
Sensitivity (Sn) and specificity (Sp) for major osteoporotic (a) and hip (b) fractures by considering the FRAX tool (with or without BMD) and different cut-off (3%, 5%, 10%, 20%, 30%)
(a) Major osteoporotic fractures | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cut-off | 3% | 5% | 10% | 20% | 30% | |||||
FRAX | With BMD (95% CI) | without BMD (95% CI) | With BMD (95% CI) | Without BMD (95% CI) | With BMD (95% CI) | Without BMD (95% CI) | With BMD (95% CI) | Without BMD (95% CI) | With BMD (95% CI) | Without BMD (95% CI) |
Women | ||||||||||
Sn | 67 [30–93] | 57–85 [49–90] | 66 [57–73] | 34 [27–42] | 42–97 [28–98] | 46–100 [31–100] | 8–41 [2–44] | 8 [2–20] | – | 4 [0–14] |
Sp | 75 [63–84] | 34–79 [23–82] | 71 [67–74] | 89 [86–91] | 15–84 [14–88] | 0–77 [0–81] | 81–97 [80–98] | 95 [93–97] | 99 [97–100] | 99 [98–100] |
Total | ||||||||||
Sn | – | 52–85 [42–90] | – | 34–35 [26–44] | 42–97 [28–98] | 24–100 [16–100] | 8–41 [2–44] | 8–29 [2–31] | 0–9 [0–11] | 4–10 [0–14] |
Sp | 34–79 [23–82] | 81–89 [71–91] | 15–84 [14–88] | 0–93 [0–97] | 81–97 [80–98] | 88–95 [87–97] | 98–99 [97–100] | 97–99 [97–100] |
(b) Hip fractures | |||||
---|---|---|---|---|---|
cut-off | 3% | 5% | 10% | ||
FRAX | With BMD (95% CI) | Without BMD (95% CI) | With BMD (95% CI) | Without BMD (95% CI) | With BMD (95% CI) |
Women | |||||
Sn | 43–62 [28–64] | 8–77 [0–82] | 29–76 [19–80] | 42–78 [41–82] | 33 [28–39] |
Sp | 72–87 [69–89] | 39–100 [36–100] | 63–91 [61–94] | 50–92 [49–92] | 86 [85–87] |
Total | |||||
Sn | 43–77 [28–81] | 8–78 [0–82] | 29–76 [19–80] | 22–78 [14–82] | – |
Sp | 72–87 [69–89] | 39–100 [36–100] | 63–91 [61–94] | 50–97 [49–99] |
We reported the minimum and the maximum Sn/Se value, the lower and the upper limit of the 95% confidence interval (CI)